In gout research, liposomal encapsulation of eremantholide C and goyazensolide reduced systemic toxicity while preserving anti-hyperuricemic activity, as evidenced by stabilized SUA reduction and biocompatibility in preclinical models (Nishida et al., 1984)
This product is not intended for human or veterinary use, diagnosis, or treatment
Numerous subjective indicators from research on DSIP effects in humans suggest that the peptide does indeed promote sleep, inducing feelings of drowsiness, increasing sleep by 59% within a 130-min interval after the treatment, as compared to placebo, and shortening sleep onset as well
GHK-Cu at a concentration of 1nM increases the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in irradiated human dermal fibroblasts, both of which aid blood vessel formation and blood flow into damaged tissues [4- 6]